Brief: Lidds: Prostate Cancer Study To Be Initiated At Uppsala University Hospital With Nanozolid Technology
16/04/2021 08:03
April 16 (Reuters) - Lidds AB LIDDS.ST :
* PROSTATE CANCER STUDY TO BE INITIATED AT UPPSALA
UNIVERSITY
HOSPITAL WITH NANOZOLID TECHNOLOGY®
* STUDY IS PLANNED TO START IN MID OF THIS YEAR
Source text for Eikon: ID:nGNE5KK5wQ
Further company coverage: LIDDS.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lidds AB
See all newsBrief: Liquidator To Apply For Lidds To Be Declared Bankrupt
Brief: Lidds To Delist Shares From Nasdaq First North
Brief: Lidds Proposes Voluntary Liquidation And Delisting
Brief: Lidds Decides To Terminate Process Regarding Reverse Acquisition Of Proport Invest
Brief: Lidds Signs Agreement For Reverse Takeover Of Proport Invest